Vivani Medical, Inc.
About Vivani Medical, Inc.
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2016
- $4.0M
- Net income
- -$26.6M
- Total assets
- $39.4M
- Market cap
- $101.8M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $27.6M
- Operating income
- -$27.6M
- Net income
- -$26.6M
- EPS (basic)
- $-0.43
- EPS (diluted)
- $-0.43
Balance sheet
- Total assets
- $39.4M
- Current assets
- $17.9M
- Total liabilities
- $23.7M
- Current liabilities
- $6.6M
- Shareholders’ equity
- $15.7M
Cash flow
- Operating cash flow
- -$24.3M
- Investing cash flow
- -$1.2M
- Financing cash flow
- $23.3M
- Net cash flow
- -$2.2M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $101.8M
- EPS (diluted)
- $-0.43
- Shares outstanding
- 88.5M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 31, 2022
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $26.6M in FY2016.
- Trading 39% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review Vivani Medical, Inc..
Write a review
News about Vivani Medical, Inc.
News & sentiment via Polygon.io
